Epigenetic and genomic profiling of chordoid meningioma: implications for clinical management

被引:0
|
作者
Elena V. Daoud
Kelsey Zhu
Bruce Mickey
Hussein Mohamed
Mandisa Wen
Michael Delorenzo
Ivy Tran
Jonathan Serrano
Kimmo J. Hatanpaa
Jack M. Raisanen
Matija Snuderl
Chunyu Cai
机构
[1] UT Southwestern Medical Center,Department of Pathology
[2] NYU Langone Medical Center,Department of Pathology
[3] UT Southwestern Medical Center,Department of Neurological Surgery
来源
Acta Neuropathologica Communications | / 10卷
关键词
Chordoid meningioma; Global methylation profile; WHO grade; Prognosis; Atypical meningioma; Brain tumor;
D O I
暂无
中图分类号
学科分类号
摘要
Chordoid meningioma is a morphological variant of meningioma designated as WHO grade 2. However, the recurrence rates varied widely in different case series, and to date, a unifying molecular genetic signature has not been identified. Among 1897 meningiomas resected at our institution, we identified 12 primary chordoid meningiomas from 12 patients. Histologically, all 12 cases had predominant (> 50%) chordoid morphology. Ten were otherwise grade 1, and two were also atypical. We performed DNA global methylation profile, copy number variation analysis, and targeted next-generation sequencing on 11 chordoid meningiomas, and compared to those of 51 non-chordoid, mostly high grade meningiomas. The chordoid meningiomas demonstrated a unique methylation profile in tSNE, UMAP, and hierarchical heatmap clustering analyses of the most differentially methylated CpGs. The most common copy number variation in chordoid meningioma was loss of 1p (7/11, 64%). Three chordoid meningiomas had 2p loss, which was significantly higher than the non-chordoid control cohort (27% vs 7.2%, p = 0.035). 22q loss was only seen in the two cases with additional atypical histological features. Chordoid meningiomas were enriched in mutations in chromatin remodeling genes EP400 (8/11,73%) KMT2C (4/11, 36%) and KMT2D (4/11, 36%), and showed low or absent NF2, TERT, SMO, and AKT1 mutations. Prognosis wise, only one case recurred. This case had atypical histology and high-grade molecular features including truncating NF2 mutation, 1p, 8p, 10, 14, 22q loss, and homozygous deletion of CDKN2A/B. Progression free survival of chordoid, otherwise grade 1 meningioma was comparable to non-chordoid WHO grade 1 meningioma (p = 0.75), and significantly better than chordoid WHO grade 2 meningioma (p = 0.019). Conclusion: the chordoid histology alone may not justify a universal WHO grade 2 designation. Screening for additional atypical histological or molecular genetic features is recommended.
引用
收藏
相关论文
共 50 条
  • [1] Epigenetic and genomic profiling of chordoid meningioma: implications for clinical management
    Daoud, Elena, V
    Zhu, Kelsey
    Mickey, Bruce
    Mohamed, Hussein
    Wen, Mandisa
    Delorenzo, Michael
    Tran, Ivy
    Serrano, Jonathan
    Hatanpaa, Kimmo J.
    Raisanen, Jack M.
    Snuderl, Matija
    Cai, Chunyu
    ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2022, 10 (01)
  • [2] Predictors of recurrence in the management of chordoid meningioma
    Winward Choy
    Leonel Ampie
    Jonathan B. Lamano
    Kartik Kesavabhotla
    Qinwen Mao
    Andrew T. Parsa
    Orin Bloch
    Journal of Neuro-Oncology, 2016, 126 : 107 - 116
  • [3] Erratum to: Predictors of recurrence in the management of chordoid meningioma
    Winward Choy
    Leonel Ampie
    Jonathan B. Lamano
    Kartik Kesavabhotla
    Qinwen Mao
    Andrew T. Parsa
    Orin Bloch
    Journal of Neuro-Oncology, 2016, 126 : 117 - 117
  • [4] Clinical Features, Treatment, and Prognostic Factors of Chordoid Meningioma: Radiological and Pathological Features in 60 Cases of Chordoid Meningioma
    Yang, Yang
    Li, Da
    Cao, Xiao-Yu
    Hao, Shu-Yu
    Wang, Liang
    Wu, Zhen
    Zhang, Jun-Ting
    WORLD NEUROSURGERY, 2016, 93 : 198 - 207
  • [5] Genomic Profiling of Anaplastic Meningioma
    Yoda, Rebecca
    Karasozen, Yigit
    Warrick, Josh
    Dorschner, Michael
    Ferriera, Manuel
    Cimino, Patrick
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2017, 76 (06): : 536 - 536
  • [6] RADIOLOGIC FEATURES ARE PROGNOSTIC FOR CLINICAL OUTCOMES OF CHORDOID MENINGIOMA
    Chen, William
    Lucas, Calixto-Hope
    Baal, Joe
    Magill, Stephen
    Wu, Ashley
    Hara, Jared
    Morin, Olivier
    Gopinath, Chetna
    Braunstein, Steve
    Bush, Nancy Ann Oberheim
    McDermott, Michael
    Perry, Arie
    Solomon, David
    Villanueva-Meyer, Javier
    Raleigh, David
    NEURO-ONCOLOGY, 2018, 20 : 155 - 155
  • [7] Genomic profiling of gynecologic cancers and implications for clinical practice
    Prendergast, Emily N.
    Elvin, Julia A.
    CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2017, 29 (01) : 18 - 25
  • [8] Clinical features and treatment of intracranial chordoid meningioma: a report of 30 cases
    Wang, Xiao-Qiang
    Mei, Guang-Hai
    Zhao, Lin
    Li, Shi-Ting
    Gong, Ye
    Zhong, Jun
    Chen, Hong
    Jiang, Cheng-Chuan
    HISTOPATHOLOGY, 2013, 62 (07) : 1002 - 1017
  • [9] Tumor comprehensive genomic profiling: clinical implications and utilization in VietNam
    Bahl, A.
    Rohatgi, N.
    Yadav, N.
    Karanth, S.
    Bharat, R.
    Joshi, N.
    Aggarwal, A.
    ANNALS OF ONCOLOGY, 2024, 35
  • [10] Genomic profiling in GIST: Implications in clinical outcome and future challenges
    Calderillo-Ruiz, German
    Perez-Yepez, Eloy Andres
    Garcia-Gamez, Maria Alejandra
    Millan-Catalan, Oliver
    Diaz-Romero, Consuelo
    Ugalde-Silva, Paul
    Salas-Benavides, Rodrigo
    Perez-Plasencia, Carlos
    Carbajal-Lopez, Berenice
    NEOPLASIA, 2024, 48